Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shivam, Mathura"'
Autor:
Andrew Ip, Donald A Berry, Eric Hansen, Andre H Goy, Andrew L Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Scott M Berry, Nicholas S Berry, Shivam Mathura, Ihor S Sawczuk, Noa Biran, Ronaldo C Go, Steven Sperber, Julia A Piwoz, Bindu Balani, Cristina Cicogna, Rani Sebti, Jerry Zuckerman, Keith M Rose, Lisa Tank, Laurie G Jacobs, Jason Korcak, Sarah L Timmapuri, Joseph P Underwood, Gregory Sugalski, Carol Barsky, Daniel W Varga, Arif Asif, Joseph C Landolfi, Stuart L Goldberg
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237693 (2020)
Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this retrospective observational cohort study drawn from electronic health r
Externí odkaz:
https://doaj.org/article/0eb4769173b44ac7b0878cbcbb1584b3
Autor:
Kristin Price, Irfan Shah, Martin Gutierrez, Andrew D. Norden, Rebecca J. Nagy, Michael Mulcahy, R.B. Lanman, Shivam Mathura, Stuart L. Goldberg
Publikováno v:
JCO Precision Oncology. :1-9
PURPOSE Genomic testing is recognized in national guidelines as essential to guide appropriate therapy selection in metastatic colorectal cancer. Previous studies report adherence to testing guidelines is suboptimal, but current testing rates have no
Autor:
Eric Hansen, Roman A Tuma, David S. Siegel, Aaron A Stein, Noa Biran, Valerie R.C. Allusson, Eric J Costanzo, Michael Marafelias, Lauren S Koniaris, Ronaldo C. Go, Vincent Vivona, George S Lin, Lisa Tank, Micky Simwenyi, Jaeil Ahn, Andre Goy, Andrew L. Pecora, Ihor S. Sawczuk, Joseph Reichman, William F Oser, Kim L Carpenter, Shivam Mathura, Louis Brusco, Urszula Bednarz, Stuart L. Goldberg, Brittany A Sinclaire, Shuqi Wang, Andrew Ip, Daniel W Varga
Publikováno v:
The Lancet Rheumatology
Summary Background Tocilizumab, a monoclonal antibody directed against the interleukin-6 receptor, has been proposed to mitigate the cytokine storm syndrome associated with severe COVID-19. We aimed to investigate the association between tocilizumab
Autor:
Shivam Mathura, Ihor S. Sawczuk, Eric Hansen, Stuart L. Goldberg, Andrew Ip, Kaushal Parikh, Joseph E. Parrillo
IntroductionCOVID-19 disproportionately affects those with comorbidities and the elderly. Hypertension is the most common pre-existing condition amongst COVID-19 patients. Upregulation of the renin-angiotensin-aldosterone system (RAAS) is common in h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69bcafbd3be9097a400c77d3d46277d5
Autor:
Andre Goy, Joseph P. Underwood, Ihor S. Sawczuk, Noa Biran, Andrew Ip, Eric Hansen, Brittany A Sinclaire, Arif Asif, Steven J. Sperber, Stuart L. Goldberg, Lisa Tank, Keith M. Rose, Donald A. Berry, Jerry Zuckerman, Andrew L. Pecora, Nicholas S. Berry, Carol L. Barsky, Sarah L. Timmapuri, Joseph Landolfi, Rani Sebti, Gregory Sugalski, Jason Korcak, Urszula Bednarz, Daniel W. Varga, Cristina Cicogna, Shivam Mathura, Bindu Balani, Scott M. Berry, Michael Marafelias, Laurie G Jacobs, Ronaldo C. Go, Julia A. Piwoz
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237693 (2020)
PLOS ONE, 15(8):e0237693
BASE-Bielefeld Academic Search Engine
PLoS ONE
PLOS ONE, 15(8):e0237693
BASE-Bielefeld Academic Search Engine
PLoS ONE
BackgroundHydroxychloroquine has been touted as a COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has been proposed as a treatment of critically ill patients.ObjectiveTo describe the association between mortality and hydroxychloroquine or toci
Autor:
Martin E, Gutierrez, Kristin S, Price, Richard B, Lanman, Rebecca J, Nagy, Irfan, Shah, Shivam, Mathura, Michael, Mulcahy, Andrew D, Norden, Stuart L, Goldberg
Publikováno v:
JCO Precision Oncology
PURPOSE Genomic testing is recognized in national guidelines as essential to guide appropriate therapy selection in metastatic colorectal cancer. Previous studies report adherence to testing guidelines is suboptimal, but current testing rates have no
Autor:
Xiaoqi Geng, Eric Hansen, Vicki Kay Fung, Andrew J. Belli, Ching-Kun Wang, Andrew D. Norden, Shivam Mathura, Priya Venkatesan, Daniel Lane
Publikováno v:
Journal of Clinical Oncology. 38:e19008-e19008
e19008 Background: Based upon interesting recent published findings, we characterize disparities in clinical characteristics, treatment patterns, and outcomes for African American (AA) patients with multiple myeloma (MM) using real-world (RW) data. M
Autor:
Kristin Price, Richard B. Lanman, Stuart L. Goldberg, Martin Gutierrez, Irfan Shah, Shivam Mathura, Rebecca Nagy, Andrew D. Norden
Publikováno v:
Journal of Clinical Oncology. 37:e15123-e15123
e15123 Background: Molecular genotyping is essential to optimal treatment selection in metastatic colon cancer (mCC) as mutations in exons 2,3,4 of KRAS and NRAS (expanded RAS) and BRAF V600E predict lack of response to anti-HER2 therapy, and microsa
Autor:
Andrew J. Belli, Shaadi Mehr, Christopher Williams, Andrew D. Norden, Kevin M. Keogh, Monica M. Matta, Michael Mulcahy, Steven E. Labkoff, Kaeleigh Farrish, Daniel Auclair, Kathryn Tanenbaum, Shivam Mathura
Publikováno v:
Journal of Clinical Oncology. 37:e19528-e19528
e19528 Background: Record retrieval on behalf of a consenting patient within the context of real-world data is not well understood. As the need for real-world data continues to expand, methods for the efficient transfer of information across consenti
Publikováno v:
Journal of Clinical Oncology. 37:e19531-e19531
e19531 Background: There is uncertainty about the prognostic and predictive significance of t(11;14), long considered a standard risk cytogenetic abnormality in multiple myeloma (MM). This translocation is associated with elevated BCL-2 expression wh